Division of Biology and Chemistry, Paul Scherrer Institute, Villigen, Switzerland.
Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
Aging Cell. 2024 Feb;23(2):e14032. doi: 10.1111/acel.14032. Epub 2023 Nov 27.
Cell-based therapies are essential for tissue regeneration and wound healing during aging. Autologous transplantation of aging cells is ineffective due to their increased senescence and reduced tissue remodeling capabilities. Alternatively, implanting reprogrammed aged cells provides unique opportunities. In this paper, we demonstrate the implantation of partially reprogrammed aged human dermal fibroblasts into in vitro aged skin models for tissue regeneration and wound healing. The partially reprogrammed cells were obtained using our previously reported, highly efficient mechanical approach. Implanted cells showed enhanced expression of extracellular matrix proteins in the large area of aged tissue. In addition, the implanted cells at wound sites showed increased extracellular matrix protein synthesis and matrix alignment. Transcriptome analysis, combined with chromatin biomarkers, revealed these implanted cells upregulated tissue regeneration and wound healing pathways. Collectively our results provide a novel, nongenetic, partial reprogramming of aged cells for cell-based therapies in regenerative medicine.
基于细胞的疗法对于衰老过程中的组织再生和伤口愈合至关重要。由于衰老细胞的衰老增加和组织重塑能力降低,自体移植衰老细胞的效果并不理想。相反,植入重编程的衰老细胞提供了独特的机会。在本文中,我们展示了将部分重编程的衰老人类真皮成纤维细胞植入体外衰老皮肤模型中以进行组织再生和伤口愈合。部分重编程的细胞是使用我们之前报道的高效机械方法获得的。植入的细胞在大面积衰老组织中表现出增强的细胞外基质蛋白表达。此外,在伤口部位植入的细胞表现出增加的细胞外基质蛋白合成和基质排列。转录组分析结合染色质生物标志物表明,这些植入的细胞上调了组织再生和伤口愈合途径。总之,我们的研究结果为再生医学中的细胞疗法提供了一种新颖的、非遗传的、部分重编程衰老细胞的方法。